Kristeleit R, Leary A, Oaknin A, Redondo A, et al. PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers. Br J Cancer 2024;131:820-831.
PMID: 38971950